A team of investigators conducted a prospective study to explore the profile of patients with OSAS and LPR at the HEMII-pH and to compare the reflux findings with LPR patients without OSAS.
Investigators analyzed the agreement among pH paper, hand-held pH meters, and laboratory pH meters for gastric pH measurements in tube-fed children with neurological impairments and GERD.
Investigators examined saliva secretion and salivary epidermal growth factor in patients with proton pump inhibitor-resistant severe reflux esophagitis.
The prevalence of Barrett esophagus has noticeably declined in patients with gastroesophageal reflux disease (GERD) over the last 2 decades. Concurrent with this finding has been an increased trend in the use of proton pump inhibitors (PPIs) and aspirin therapy, as well as a decrease in cigarette smoking. It is therefore possible that these modifiable…
A team of investigators assessed outcomes following one anastomosis gastric bypass in patients with gastroesophageal reflux disease and/or hiatal hernia.
The researchers conducted a literature search for studies that reported long-term outcomes of transoral incisionless fundoplication for treating refractory GERD and then pooled the data.
The aim of this study was to identify absolute risks and risk factors of short-term outcomes in younger patients with primary laparoscopic and secondary antireflux surgery.
A team of investigators sought to determine the ability of the Cytosponge to detect the persistence of Barrett esophagus following eradication therapy.
Budesonide oral suspension improved histologic, endoscopic, and both histologic and symptomatic outcomes in children with eosinophilic esophagitis compared with placebo.
A team of investigators conducted a prospective, single-center, observational study at the Cleveland Clinic to determine the safety and feasibility of IT-knife tunneling and C-shaped incision endoscopic submucosal dissection of the esophagus.
A team of investigators sought to determine how concomitant proton pump inhibitor treatment influences response to infliximab therapy in patients with inflammatory bowel disease.
Researchers aimed to describe the impact of the COVID-19 pandemic on the diagnosis of Barrett esophagus and esophagogastric cancer in Northern Ireland.